Calton & Associates’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
Calton & Associates's BCAT Position: Q1 2026 in Review
Calton & Associates increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 3.6% in Q1 2026, buying an estimated $5.64K and bringing the position to 11,069 shares worth $156K. The position accounts for 0.02% of the portfolio, ranked #426.
Calton & Associates first reported a position in BCAT in Q4 2021 and has held it in 17 quarters since. The position peaked at $422K in Q1 2024. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- Calton & Associates held 11,069 shares of BlackRock Capital Allocation Term Trust worth $156K as of Q1 2026.
- Calton & Associates bought 383 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $5.64K.
- BlackRock Capital Allocation Term Trust made up 0.02% of Calton & Associates's portfolio in Q1 2026, its #426 holding.
- Calton & Associates first reported a position in BlackRock Capital Allocation Term Trust in Q4 2021 and has held it in 17 quarters since.
- Calton & Associates's BlackRock Capital Allocation Term Trust position peaked at $422K in Q1 2024.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on Calton & Associates's 13F filing for Q1 2026, filed 13 May 2026.